1-butyrylamino-1,2,3,4-tetrahydronaphthalene | 1234940-50-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: 1-butyrylamino-1,2,3,4-tetrahydronaphthalene
• 英文别名: N-(1,2,3,4-tetrahydronaphthalen-1-yl)butyramide；N-(1,2,3,4-tetrahydronaphthalen-1-yl)butanamide
• CAS: 1234940-50-1
• 化学式: C₁₄H₁₉NO
• mdl: MFCD20538280
• 分子量: 217.311
• InChiKey: USMPURSJYSHMKL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] SUBSTITUTED SULFONAMIDOPROPIONAMIDES AND METHODS OF USE<br/>[FR] SULFONAMIDOPROPIONAMIDES SUBSTITUES ET PROCEDES D'UTILISATION
  申请人：AMGEN INC

  公开号：WO2006036664A1

  公开（公告）日：2006-04-06

  This invention is in the field of pharmaceutical agents and specifically relates to compounds, compositions, uses and methods for treating inflammation-related disorders, including pain.

  这项发明属于药物代理领域，具体涉及化合物、组合物、用途和治疗与炎症相关的疾病，包括疼痛的方法。
• [EN] TETRALINE SULFONAMIDE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS<br/>[FR] DÉRIVÉS DE SULFONAMIDE DE TÉTRALINE POUR L'UTILISATION DANS LE TRAITEMENT DE TROUBLES DE PROLIFÉRATION
  申请人：UNIV NOTRE DAME DE LA PAIX

  公开号：WO2012175654A1

  公开（公告）日：2012-12-27

  Tetraline sulfonamides derivatives highly specific towards CA IX and/or CA XII human carbonic anhydrase for targeting solid tumors.

  四环磺胺衍生物对人类碳酸酐酶CA IX和/或CA XII具有高度特异性，用于靶向固体肿瘤。
• Quinolone Neuropeptide S Receptor Antagonists
  申请人：Barrow James C.

  公开号：US20110212946A1

  公开（公告）日：2011-09-01

  The present invention is directed to quinolone compounds which are antagonists of neuropeptide S receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which the neuropeptide S receptor is involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the neuropeptide S receptor is involved.

  本发明涉及喹诺酮化合物，它们是神经肽S受体拮抗剂，可用于治疗或预防神经系统和精神疾病，以及涉及神经肽S受体的疾病。本发明还涉及包含这些化合物的制药组合物，以及这些化合物和组合物在预防或治疗涉及神经肽S受体的疾病中的用途。
• SUBSTITUTED SULFONAMIDOPROPIONAMIDES AND METHODS OF USE
  申请人：Amgen, Inc

  公开号：EP1799637A1

  公开（公告）日：2007-06-27
• SUBSTITUTED ARYL OR HETEROARYLSULFONYLBUTANAMIDES FOR USE AS ANTI-INFLAMMATORY AGENTS
  申请人：Amgen, Inc

  公开号：EP1856074A2

  公开（公告）日：2007-11-21